The use of checkpoint inhibitors in patients with hepatocellular carcinoma [interview] Journal Article


Author: Abou-Alfa, G. K.
Article Title: The use of checkpoint inhibitors in patients with hepatocellular carcinoma [interview]
Keywords: united states food and drug administration; immunotherapy; dose-response relationship; carcinoma, hepatocellular -- drug therapy; antibodies, monoclonal -- therapeutic use; cancer patients; hepatitis c -- risk factors; immunotherapy -- adverse effects; carcinoma, hepatocellular -- immunology; hepatitis b -- risk factors; nivolumab -- therapeutic use; abou-alfa gk
Journal Title: Gastroenterology & Hepatology
Volume: 15
Issue: 1
ISSN: 1554-7914
Publisher: Millennium Medical Publishing, Inc  
Date Published: 2019-01-01
Start Page: 48
End Page: 50
Language: English
ACCESSION: 134304243
PROVIDER: EBSCOhost
PROVIDER: cin20
DOI/URL:
Notes: Accession Number: 134304243 -- Entry Date: 20190131 -- Revision Date: 20190131 -- Publication Type: Article -- Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 101262648. -- Source: cin20
MSK Authors
  1. Ghassan Abou-Alfa
    210 Abou-Alfa